Differences in distribution and antimicrobial susceptibility of anaerobes isolated from complicated intra-abdominal infections versus diabetic foot infections

被引：15

作者：

Claros, Marina ^{[1
]}

Citron, Diane M. ^{[2
]}

Goldstein, Ellie J. C. ^{[2
,3
]}

Merriam, C. Vreni ^{[2
]}

Tyrrell, Kerin L. ^{[2
]}

机构：

[1] Roche Diagnost Int AG, Rotkreuz, Switzerland

[2] R M Alden Res Lab, Culver City, CA 90230 USA

[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

来源：

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2013年 / 76卷 / 04期

关键词：

Anaerobes; Diabetic foot infection; Intra-abdominal infection; Resistance; Finegoldia magna; Bacteroides fragilis; Levofloxacin; Ertapenem; CARBAPENEMS; RESISTANCE;

D O I：

10.1016/j.diagmicrobio.2013.04.025

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Few labs isolate and perform susceptibility tests on anaerobes; therefore, we studied the differences between 1185 anaerobes isolated from complicated intra-abdominal infections and 470 isolated from moderate to severe diabetic foot infections. They differed markedly in the distribution of species, including Bacteroides fragilis and anaerobic Gram-positive cocci, as well as in resistance patterns, especially to fluoroquinolones. (c) 2013 Elsevier Inc. All rights reserved.

引用

页码：546 / 548

页数：3

共 50 条

[11] Management of complicated intra-abdominal infections
Barie, PS
JOURNAL OF CHEMOTHERAPY, 1999, 11 (06) : 464 - 477
[12] Treatment of complicated intra-abdominal infections: doripenem versus meropenem
Lucasti, C.
Jasovich, A.
Umeh, O.
Jiang, J.
Kaniga, K.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S212 - S212
[13] Antimicrobial treatment for intra-abdominal infections
Mazuski, John E.
EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (17) : 2933 - 2945
[14] Antimicrobial treatment of intra-abdominal infections
Elsakr, R
Johnson, DA
Younes, Z
Oldfield, EC
DIGESTIVE DISEASES, 1998, 16 (01) : 47 - 60
[15] ANTIMICROBIAL RESISTANCE PROFILE IN COMPLICATED INTRA-ABDOMINAL INFECTIONS IN DEVELOPING COUNTRY
Shahzad, N.
Alvi, A. R.
Quratulain, R.
Farooqi, J.
SHOCK, 2014, 41 : 41 - 42
[16] In vitro activity of moxifloxacin against 923 anaerobes isolated from human intra-abdominal infections
Goldstein, EJC
Citron, DM
Warren, YA
Tyrrell, KL
Merriam, CV
Fernandez, H
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) : 148 - 155
[17] Susceptibility of anaerobic flora recovered from complicated intra-abdominal infections to clinafloxacin and imipenem
Hopkins, JA
Wilson, SE
Shimabukuro, J
Chavez, C
ANAEROBE, 1999, 5 (3-4) : 435 - 437
[18] Eravacycline for the treatment of complicated intra-abdominal infections
Montravers, Philippe
Zappella, Nathalie
Tran-Dinh, Alexy
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2019, 17 (11) : 851 - 863
[19] Complicated intra-abdominal infections: pathogens, resistance
Bodmann, K. -F.
CHIRURG, 2010, 81 (01): : 38 - 49
[20] Eravacycline for the treatment of complicated intra-abdominal infections
Wang, Hongmei
Nguyen, Namphi
Cruz, Christopher
ADVANCES IN DIGESTIVE MEDICINE, 2021, 8 (04) : 203 - 210

← 1 2 3 4 5 →